- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/60 - N-oxides
Patent holdings for IPC class C07D 215/60
Total number of patents in this class: 42
10-year publication summary
|
8
|
1
|
3
|
1
|
2
|
3
|
2
|
3
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zydus Lifesciences Limited | 131 |
7 |
| Astellas Pharma Inc. | 1036 |
2 |
| Cadila Healthcare Limited | 299 |
2 |
| Exelixis, Inc. | 390 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2976 |
2 |
| Firmenich Incorporated | 157 |
2 |
| Laurel Therapeutics Ltd. | 6 |
2 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Pfizer Inc. | 3370 |
1 |
| Bayer Cropscience AG | 1882 |
1 |
| Bayer Pharma AG | 1025 |
1 |
| Board of Regents, The University of Texas System | 6062 |
1 |
| Vertex Pharmaceuticals Incorporated | 1595 |
1 |
| Korea Advanced Institute of Science and Technology | 4589 |
1 |
| University of South Florida | 1872 |
1 |
| BIAL - Portela & CA, S.A. | 214 |
1 |
| Department of Veterans Affairs | 113 |
1 |
| Incyte Corporation | 1063 |
1 |
| Institute for Basic Science | 377 |
1 |
| Medicines for Malaria Venture MMV | 4 |
1 |
| Other owners | 10 |